Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pain Management
Significant pain relief in children demonstrated by Corgentech's ALGRX 3268 in trial
March 24th, 2006
Corgentech, Inc., (CGTK) announced that researchers presented pivotal phase III trial results from the second of 2 phase III trials demonstrating that children undergoing medical procedures requiring venipunctures and intravenous line placements treated with ALGRX 3268 experienced significantly superior pain relief in just 1-3 minutes versus those receiving placebo. Importantly, the study also showed ALGRX 3268 was well-tolerated. The dataset, from which top-line data were reported in November 2005, was presented at the Society for Pediatric Anesthesia meeting in Fort Myers, Florida. Corgentech plans to file a new drug application with the U.S. Food...
Source: Drug Week (2006-03-24)
|
